Acambis PLC - Update On MVA Procurement

July 26, 2006 |

1 min read

Acambis plc ("Acambis") (LSE: ACM, NASDAQ: ACAM) provides an update on the US Government tender process relating to Modified Vaccinia Ankara ("MVA") attenuated smallpox vaccine.

Regulatory Europe

MORE ON THIS TOPIC

Stagflation, economic slow down or recession while inflation high up, GDP growth decrease causing by unemployment concept, fearful businessman riding fall down economic graph with inflation high up.

Complete response letters

REGENXBIO’s Hunter Syndrome Gene Therapy Fails To Win FDA Nod

February 10, 2026

·

2 min read

·

Tristan Manalac

Red round circle with a pause button or icon against yellow background.

Gene therapy

Liver Toxicities Force Pause on Two Dose Groups of UniQure’s Mid-Stage Fabry Study

February 9, 2026

·

1 min read

·

Tristan Manalac

Magnifying glass focusing on number 2026 with target icon on yellow background. Concept for new year focus, business goals, trends, planning, strategy, vision, success, and future opportunities.

Opinion

2025 Reshaped the FDA. What Will 2026 Hold?

February 9, 2026

·

6 min read

·

Digital compass. Business strategic explorer, Vision crisis, Mission path, Agency creative, Digital strategy, Market decision, Achievement strategy, Financial stock, Company vision concepts

Policy

FDA Policy Tracker 2026: Priority Vouchers Questioned, PRVs Return

February 9, 2026

·

5 min read

·

Heather McKenzie